Restless Legs Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Restless Legs Syndrome Clinical Trials Market Report Overview
The restless legs syndrome clinical trial market research report provides an overview of the restless legs syndrome clinical trials scenario. The report provides top-line data relating to the clinical trials on restless legs syndrome. It also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type.
Restless Legs Syndrome Clinical Trials Market Segmentation by Regions and Countries
The key regions in the restless legs syndrome clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America, among others.
In a country-wise analysis, as of November 2022, the US has the highest number of restless legs syndrome clinical trials, followed by Germany, Spain, Canada, Iran, Japan, Austria, China, the UK, and Italy.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, Germany has the highest proportion of restless legs syndrome to central nervous system clinical trials. Moreover, out of all the clinical trials conducted in the G7 countries, the majority were in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Russia has the highest proportion of restless legs syndrome to central nervous system clinical trials. Out of all the clinical trials conducted in the E7 countries, the majority were in China.
Restless Legs Syndrome Clinical Trials Analysis by Regions
For more regional insights into the restless legs syndrome clinical trials market, download a free report sample
Restless Legs Syndrome Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the restless legs syndrome clinical trials market are institution, company, and the government. Out of them, company dominates the market.
Restless Legs Syndrome Clinical Trials Market Analysis by Sponsor Types
For more sponsor type insights into the restless legs syndrome clinical trials market, download a free report sample
Restless Legs Syndrome Clinical Trials Market - Competitive Landscape
The leading sponsors in the restless legs syndrome clinical trials market are UCB SA, GSK plc, C. H. Boehringer Sohn AG & Co KG, Mundipharma International Ltd, G.L. Pharma GmbH, Acino International AG, Altasciences Co Inc, Astellas Pharma Inc, Apotex Pharmaceutical Holdings Inc, and Daiichi Sankyo Co Ltd. Out of them, UCB SA has conducted the highest number of restless legs syndrome clinical trials.
Restless Legs Syndrome Clinical Trials Market Analysis by Sponsors
To know more about the leading players in the restless legs syndrome clinical trials market, download a free report sample
Restless Legs Syndrome Clinical Trials Market Report Overview
Key Regions | North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America |
Key Countries | The US, Germany, Spain, Canada, Iran, Japan, Austria, China, the UK, and Italy |
Key Sponsor Types | Institution, Company, and Government |
Leading Sponsors | UCB SA, GSK plc, C. H. Boehringer Sohn AG & Co KG, Mundipharma International Ltd, G.L. Pharma GmbH, Acino International AG, Altasciences Co Inc, Astellas Pharma Inc, Apotex Pharmaceutical Holdings Inc, and Daiichi Sankyo Co Ltd |
Scope
- The report provides a snapshot of the global clinical trials landscape
- The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
- The report reviews the top companies involved and enlists all trials (trial title, phase, and status) pertaining to the company
- The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with a reason for unaccomplishment
- The report provides enrollment trends for the past five years
- The report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies concerning investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top-level analysis of the global clinical trials market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
GSK plc
C. H. Boehringer Sohn AG & Co KG
Mundipharma International Ltd
G.L. Pharma GmbH
Acino International AG
Altasciences Co Inc
Astellas Pharma Inc
Apotex Pharmaceutical Holdings Inc
Daiichi Sankyo Co Ltd
Table of Contents
Frequently asked questions
-
What are the key regions in the restless legs syndrome clinical trials market?
The key regions in the restless legs syndrome clinical trials market are North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America, among others.
-
What are the key countries in the restless legs syndrome clinical trials market?
The key countries in the restless legs syndrome clinical trials market are the US, Germany, Spain, Canada, Iran, Japan, Austria, China, the UK, and Italy.
-
What are the key sponsor types in the restless legs syndrome clinical trials market?
The key sponsor types in the restless legs syndrome clinical trials market are institution, company, and the government.
-
Who are the leading sponsors in the restless legs syndrome clinical trials market?
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Central Nervous System reports

